Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney Transplant
NCT01502267
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
2
Enrollment
OTHER
Sponsor class
Conditions
End Stage Renal Disease
Interventions
DRUG:
High dose IVIG and B cell depleting agents
Sponsor
Seoul National University Hospital
Collaborators
[object Object]